T. Rowe Price Associates’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $98K | Hold |
|
|||||
|
2021
Q2 | $131K | Sell |
|
|||||
|
2021
Q1 | $172K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $5.78M | Sell |
|
|||||
|
2019
Q4 | $8.79M | Sell |
|
|||||
|
2019
Q3 | $9.97M | Sell |
|
|||||
|
2019
Q2 | $8.34M | Sell |
|
|||||
|
2019
Q1 | $12.4M | Buy |
|
|||||
|
2018
Q4 | $10.1M | Sell |
|
|||||
|
2018
Q3 | $18.8M | Sell |
|
|||||
|
2018
Q2 | $12.6M | Sell |
|
|||||
|
2018
Q1 | $10.4M | Buy |
|
|||||
|
2017
Q4 | $10.1M | Buy |
|
|||||
|
2017
Q3 | $12.7M | Sell |
|
|||||
|
2017
Q2 | $16.9M | Buy |
|
|||||
|
2017
Q1 | $4.94M | Buy |
|
|||||
|
2016
Q4 | $7.06M | Sell |
|
|||||
|
2016
Q3 | $9.04M | Buy |
|